Arcus Biosciences, Inc.

RCUS

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001724521

SEC filings (opens in a new tab)

In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Arcus Biosciences, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025 All holders in Q1 2025

13F holders of RCUS: Q1 2025 compared with Q2 2025
Measure	Q1 2025	Of which not filed for Q2 2025	Q2 2025	Change
Holders	187	1	186	0
Shares	97.2M	13	99.7M	+2.51M (+2.6%)
Value	$763.3M	$102	$811.5M	+$48.2M (+6.3%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Arcus Biosciences, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to RCUS in Q2 2025
Institution	Shares	Value	% of portfolio
Integral Health Asset Management, LLC	300,000	$2.44M	0.23%
Susquehanna Portfolio Strategies, LLC	247,966	$2.02M	0.04%
Jain Global LLC	199,963	$1.63M	0.03%
Balyasny Asset Management LLC	162,812	$1.33M	0.00%
Group One Trading, L.P.	122,827	$999.8K	0.03%
Qube Research & Technologies Ltd	84,049	$684.2K	0.00%
XTX Topco Ltd	35,998	$293.0K	0.01%
Creative Planning	28,858	$234.9K	0.00%
CI Private Wealth, LLC	22,067	$179.6K	0.00%
Nomura Holdings Inc	15,603	$127.0K	0.00%
DRW Securities, LLC	13,285	$108.1K	0.01%
Point72 (DIFC) Ltd	12,796	$104.2K	0.01%
Brevan Howard Capital Management LP	11,972	$97.5K	0.00%
Point72 Hong Kong Ltd	7,991	$65.0K	0.00%
Caitong International Asset Management Co., Ltd	417	$3.39K	0.00%
Massmutual Trust Co FSB	269	$2.19K	0.00%
MAI Capital Management	242	$1.97K	0.00%
Parkside Financial Bank & Trust	85	$693	0.00%
Jones Financial Companies LLLP	67	$533	0.00%
Fortitude Family Office, LLC	60	$488	0.00%
Annis Gardner Whiting Capital Advisors, LLC	48	$391	0.00%
Atlantic Trust, LLC	27	$220	0.00%
Essential Partners LLC	25	$204	0.00%
Larson Financial Group LLC	17	$138	0.00%
Capital Advisors, Ltd. LLC	1	$0	0.00%
Avion Wealth	64	$0	0.00%

Sold out (26)

Institutions that held Arcus Biosciences, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of RCUS in Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Cutter Capital Management, LP	731,818	$5.74M
Campbell & CO Investment Adviser LLC	165,474	$1.30M
Winton Group Ltd	115,595	$907.4K
Marshall Wace, LLP	112,051	$879.6K
Mangrove Partners	83,997	$659.4K
Tudor Investment Corp Et Al	53,466	$419.7K
Capula Management Ltd	29,053	$228.1K
Corebridge Financial, Inc.	28,810	$226.2K
Handelsbanken Fonder AB	24,800	$195.0K
Gilder Gagnon Howe & Co LLC	24,016	$188.5K
Acadian Asset Management LLC	22,932	$180.0K
Oxford Asset Management LLP	22,420	$176.0K
Amundi	23,993	$172.0K
Universal- Beteiligungs- und Servicegesellschaft mbH	17,631	$138.4K
Fox Run Management, L.L.C.	16,985	$133.3K
Bayesian Capital Management, LP	14,200	$111.5K
Exchange Traded Concepts, LLC	13,922	$109.3K
Graham Capital Management, L.P.	13,025	$102.2K
CIBC World Markets Corp	12,065	$94.7K
Pictet Asset Management Holding SA	10,452	$82.0K
Point72 Asia (Singapore) Pte. Ltd.	10,396	$81.6K
STRS Ohio	8,500	$66.7K
Quadrant Capital Group LLC	3,721	$29.2K
True Wealth Design, LLC	126	$990
Assetmark, Inc	43	$338
Continuum Advisory, LLC	33	$259

Not filed for Q2 2025 yet (1)

Institutions that held Arcus Biosciences, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCUS in Q1 2025 that haven't filed for Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Lindbrook Capital, LLC	13	$102